Corporation
Emergent BioSolutions Canada Inc.
- Meetings this Parliament
- 11
- With MPs
- 2
- Since Nov 2021
- 11
- Active registrations
- 1
Most recent reported meeting: Sep 29, 2026.
Lobbying by Emergent BioSolutions Canada Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Billy Morin Conservative 1
- Ben Carr Liberal 1
Institutions
- Innovation, Science and Economic Development Canada (ISED)4
- National Defence (DND)3
- Indigenous Services Canada (ISC)2
- House of Commons2
- Prime Minister's Office (PMO)1
Registrations in effect
In-house (corporation) In effect since Sep 29, 2026
Filed by Paul Williams, SVP, Products Business and President, Canada
Lobbyists
- Christopher Frech · Executive Advisor to the CEO
- Christopher Sinclair · VP, GM Medical Countermeasures Business; Government Business
- Danielle Portnik · Country Manager and Head of Products Business
- Darren Ross · Senior Director, International Preparedness; Government Business
- Dvorah Richler · Sr. Director, Government Relations and Market Access
- Erica Louttit · Senior Manager, Indigenous Health Solutions
- Paul Williams · SVP Products Business and President, Canada
- Shawn McLaren · Director, Indigenous & Public Programs
Institutions they may lobby: Canadian Centre for Occupational Health and Safety (CCOHS), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prairies Economic Development Canada (PrairiesCan), Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC)
What they're lobbying on (3)Hide details
- To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg.
- To increase access to publicly funded nasal naloxone.
- To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
Registration 959368-380100-5. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Paul Williams · In-house (corporation)
- Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
- Alyth Roos · Special Assistant Policy, Prime Minister's Office (PMO)
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund. Read more
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg.
-
Reported by Paul Williams · In-house (corporation)
- Ben Carr · Member of Parliament
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg. Read more
To increase access to publicly funded nasal naloxone.
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
-
Reported by Paul Williams · In-house (corporation)
- Jennifer Novak · Director Général, Indigenous Services Canada (ISC)
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
-
Reported by Paul Williams · In-house (corporation)
- Jennifer Novak · Director General, Indigenous Services Canada (ISC)
- Harnoor Kochar · Regional Advisor, Indigenous Services Canada (ISC)
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
-
Reported by Paul Williams · In-house (corporation)
- Quinn Ferris · Regional Advisor, National Defence, National Defence (DND)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg. Read more
-
Reported by Paul Williams · In-house (corporation)
- Billy Morin · Member of Parliament
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
-
Reported by Paul Williams · In-house (corporation)
- Jocelyn Milburn · Director, Health Emergency Readiness Canada (HERC), Innovation, Science and Economic Development Canada (ISED)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. Read more
-
Reported by Paul Williams · In-house (corporation)
- Timothy Smith · Deputy Program Manager, National Defence (DND)
- Wendy Hepburn · Deputy Director, National Defence (DND)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. Read more
-
Reported by Paul Williams · In-house (corporation)
- Jocelyn Milburn · Director, HERC, Innovation, Science and Economic Development Canada (ISED)
- Alison McConnell · Deputy Director, Innovation, Science and Economic Development Canada (ISED)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. Read more
-
Reported by Paul Williams · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. Read more
-
Reported by Paul Williams · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Wendy Hadwen · Assistant Deputy Minister, National Defence (DND)
- Wendy Hepburn · Deputy Director, National Defence (DND)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.